Table 2.
Main results of pain outcomes from included trials of cryoanalgesia for postoperative pain.
| Author, year | Procedure | Comparator | Pain outcome measures | Pain measured at rest, with movement, or not specified? | Follow-up time | Pain outcomes (s) |
| Brichon [33], 1994 | Thoracotomy | TE, OA, NOA (Group B) | VAS | Not specified | Days 1–12 | Patients in the epidural group had better pain relief than the cryoanalgesia group on POD 1 and 2. |
| Ju [36], 2008 | Thoracotomy | TE, OA | NRS, chronic pain incidence | Rest and movement | Days 1–3, Months 1, 3, 6, 12 | No significant difference for acute pain. Fewer patients in the epidural group reported moderate or severe chronic pain on POM 6. |
| Yang [41], 2004 | Thoracotomy | TE, OA, NOA | VAS, NRS, chronic pain incidence | Rest and movement | Days 1–7, Months 1, 3, 6 | Patients who received cryoanalgesia with epidural had less pain on movement than epidural alone on POD 7. Incidence and severity of post-thoracotomy chronic pain at POM3 was worse at rest in the cryoanalgesia and epidural group than in the epidural alone group. |
| Frequency of morphine consumption | N/A | Days 1–7 | Patients who received cryoanalgesia with epidural used less analgesic than epidural alone on POD 7. | |||
| Mustola [42], 2011 | Thoracotomy | TE, OA, NOA | VAS, VPS | Rest and movement | Days 1–7, Months 1, 2, 6 | Patients who received cryoanalgesia with epidural had more pain at rest than epidural alone at 12 h, POD 2, and POM 2. |
| Frequency of epidural bolus; Oxycodone requirements | N/A | Days 1–3 | No significant difference | |||
| Momenzadeh [25], 2011 | Thoracotomy | OA | VAS | Not specified | Days 1–7 | Patients who received cryoanalgesia had significantly less pain than the control group on POD 1–7. |
| Pethidine consumption | N/A | Days 1–7 | Mean pethidine consumption was significantly higher in the control group than the cryoanalgesia group on POD 1. Patients in the control group used pethidine until POD 7, whereas patients in the cryoanalgesia group stopped on POD 4. | |||
| Ma [29], 2009 | Thoracotomy | OA | VAS | Not specified | Days 1, 3, 5, 9, Months 1–3, 6 | Compared with the control group, pain scores in the cryoanalgesia group were significantly lower at days 1, 3, 5, 9, and 30. |
| Pethidine consumption | N/A | Days 1, 3, 5, 9 | Patients in the cryoanalgesia use used significantly less pethidine at all time points. | |||
| Katz [37], 1980 | Thoracotomy | INB, OA | NRS | Not specified | Days 1, 3, 5 | At all points in follow up, the cryoanalgesia group had significantly less pain than the comparator group. |
| Morphine consumption | N/A | Day 1 | Compared with cryoanalgesia, comparator patients required significantly more morphine on POD 1 | |||
| Keenan [32], 1983 | Thoracotomy | OA (Group 4) | VAS | Rest and movement | Days 1, 2 | Cryoanalgesia reduced pain significantly, compared with comparator at rest and on movement. Combining cryoanalgesia with indomethacin appeared to have an additive effect. |
| Papaveretum consumption | N/A | Day 1 | The combination of indomethacin and cryoanalgesia significantly reduced the need for opioid analgesia compared with comparator. | |||
| Muller [30], 1989 | Thoracotomy | OA,/NOA | Non-standard pain scale (0–4) | Not specified | Days 1–3, 5, 7 | No significant difference. |
| Methadone consumption | N/A | Days 1–3, 5, 7 | No significant difference. | |||
| Miguel [35], 1993 | Thoracotomy | OA (Group 4) | VAS, chronic pain incidence | Not specified | Days 1, 2, 5, Month 12 | Patients receiving epidural morphine had significantly lower pain scores than patients receiving cryoanalgesia on POD 0. Patients receiving cryoanalgesia had significantly less incidence of post-thoracotomy pain syndrome at POM 3. |
| Morphine consumption | N/A | Days 1, 2, 5 | No significant difference. | |||
| Moorjani [27], 2001 | Thoracotomy | OA | VAS | Not specified | Days 1–7, 10, 20, Month 1 | Patients receiving cryoanalgesia had significantly less pain on POD 1–7. |
| Pethidine consumption | N/A | Days 1–7 | Patients receiving cryoanalgesia used significantly less pethidine on POD 1–6 than patients receiving conventional analgesia. | |||
| Joucken [38], 1987 | Thoracotomy | INB, OA (Group 2) | Frequency of piritramide consumption | N/A | Hours 1-36 | Patients in the cryoanalgesia group used significantly fewer narcotic injections compared to control and intercostal block groups. |
| Ba [23], 2014 | Thoracotomy | NOA | VAS | Not specified | Days 1–3, 7 Months 1, 6 | Patients receiving cryoanalgesia had significantly less pain than patients receiving parecoxib on POD 1–3, 7 and POM 1. |
| Pastor [31], 1996 | Thoracotomy | OA, NOA | Non-standard pain scale (0–5) | Not specified | Days 1–7 | Patients receiving cryoanalgesia had significantly less pain on POD 1–7. |
| Frequency of aminopyrine consumption | N/A | Days 1–7 | Patients receiving cryoanalgesia used significantly less major analgesia on POD 1–7 than comparator. | |||
| Roberts [39], 1988 | Thoracotomy | INB, OA | VAS (0–12) | Not specified | Days 1–3 | Patients receiving cryoanalgesia had significantly less pain on POD 1–3 than patients receiving bupivacaine block. |
| Pethidine consumption | N/A | Days 1–3 | Patients receiving cryoanalgesia used significantly less pethidine on POD 1–3 than patients receiving bupivacaine block. | |||
| Roxburgh [34], 1987 | Thoracotomy | LE, OA, NOA | VPS | Not specified | Days 1–14 | No significant difference. |
| OA/NOA consumption | N/A | Days 1–14 | No significant difference. | |||
| Gwak [26], 2004 | Thoracotomy | OA | VAS, chronic pain incidence | Rest and movement | Days 1–7 | No significant difference. |
| Fentanyl consumption | N/A | Days 1–7 | No significant difference. | |||
| Sepsas [28], 2013 | Thoracotomy | OA, NOA | VPS | Rest and coughing | Days 1–7, Week 2, Months 1, 2 | Patients receiving cryoanalgesia had significantly less pain at rest at all timepoints, compared to comparator. . . |
| Morphine consumption; OA/NOA frequency of consumption | N/A | Days 1–7, Week 2, Months 1, 2 | Patients receiving cryoanalgesia used significantly less morphine at all timepoints, compared to comparator (Data reported in 6-h intervals). | |||
| Lu [24], 2013 | Esophagectomy with thoracotomy | NDMIF, OA, NOA | VAS | Not specified | Days 1–7, Months 1, 3, 6, 9, 12 | Patients receiving cryoanalgesia had significantly more pain at POM 6, 9, 12 than patients receiving NDIMF. . |
| Incidence of OA/NOA consumption | N/A | Days 1–7, Months 1, 3, 6, 9, 12 | Patients receiving cryoanalgesia used significantly more likely to be using oral pain medication at POM 6, 9, 12 than patients receiving NDIMF. . |
|||
| Callesen [19], 1998 | Herniorrhaphy | OA, NOA | Non-standard pain scale (0–3) | Rest and movement | Days 1–7, Months 1, 2 | No significant difference. |
| Acetaminophen consumption | N/A | Days 1–7 | No significant difference. | |||
| Khiroya [20], 1986 | Herniorrhaphy | OA, NOA | VAS | Rest | Days 1, 2, Month 3 | No significant difference. |
| Pethidine consumption; Distalgesic consumption | N/A | – | No significant difference. | |||
| Ahmadnia [21], 2010 | Nephrectomy | OA | Morphine consumption | N/A | Days 1, 2 | No significant difference. |
| Robinson [22], 2000 | Tonsillectomy | OA, NOA | VAS | Not specified | Days 1–10 | Over the duration of follow up, patients receiving cryoanalgesia had significantly less pain than comparator group. . |
| OA/NOA consumption | N/A | Month 1 | No significant difference. | |||
| Graves [40], 2019 | Nuss Procedure | TE, OA, NOA | VAS | Not specified | Days 1, 3, 5, Week 2, Months 1, 3, 12 | No significant difference. |
| OA consumption (oral morphine equivalents) | N/A | Days 1–3 | Patients who received cryoanalgesia used significantly less opioids throughout the postoperative stay than patients receiving epidural. | |||
VAS: Visual analog scale; NRS: Numeric rating scale; VPS: Verbal pain scale; NDIMF: Non-divided intercostal muscle flap; POD: Post-operative day; POM: Post-operative month; IC: Intercostal; OA: Opioid analgesia; NOA: Non-Opioid analgesia; TE: Thoracic epidural; INB: Intercostal nerve block; LE: Lumbar Epidural; NDIMF: Non-divided intercostal muscle flap.